Trusted News Discovery Since 2008
{{/content}}
Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects
Credit: IndiaTimes- Published 2 weeks ago
Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine manufacturer Bharat Biotech emphasized the safety of its indigenous vaccine, Covaxin, aiming to alleviate public apprehensions regarding Covid...
Video credit: Oneindia
Published 2 weeks ago - 03:03
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia
After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their daughter, who succumbed to post-vaccination complications. Safety concerns prompted regulatory scrutiny and legal action, despite the vaccine's proven efficacy against Covid-19.
#covishield #covishieldsideeffects #covishieldnews #covishieldvaccine #covishieldsideeffectsnews #covishieldnewstoday #covishieldvaccinenews #Oneindia #Oneindianews
~PR.320~GR.123~ED.155~HT.318~
You are here
Related videos from verified sources
AstraZeneca and deadly “rare” blood clots - it ISN'T only AstraZeneca they are anything BUT rare.. 00:43
Credit: Rumble - Published 1 week ago
AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court 05:11
Credit: Oneindia - Published 1 week ago
Political uproar in India after Astrazeneca admits blood clot side effect 06:02
Credit: Rumble - Published 2 weeks ago